Chris Gent
From Wikipedia, the free encyclopedia
Sir Christopher Gent (Beckenham, Kent, May 10, 1948) is the former chief executive officer of Vodafone, a British cell-phone company. After retiring in July 2003, he was awarded the honorary title of Company's President for Life on his departure as a mark of his achievement in developing the company, till his resignation from that position in March 2006. The title carried no salary, nor any advisory responsibilities, but was a symbolic link to the business that few former chief executives are allowed to retain.
Gent, widely credited with transforming Vodafone from a small British company into a global giant, and who engineered Vodafone's 178 billion euro ($212 billion) historic purchase of Germany's Mannesmann in 2000.
He is now Chairman of GlaxoSmithKline, a British pharmaceutical company.
From October 2005 to October 2006 he served on the Tax Reform Commission, established by the Shadow Chancellor of the Exchequer, George Osborne MP.
[edit] Quotes
"These are excellent results." — Chris Gent in reference to a Vodafone annual report which included a record US $19.8 billion loss (year unknown).
GlaxoSmithKline plc |
Corporate Directors: Lawrence Culp | Crispin Davis | Jean-Pierre Garnier | Chris Gent | Julian Heslop | Deryck Maughan | Ian Prosser | Ronaldo Schmitz | Lucy Shapiro | Robert Wilson | Tadataka Yamada |
Products: Bupropion (Zyban) | Co-amoxiclav (Augmentin) | Paroxetine (Paxil, Seroxat, Aropax) | Rosiglitazone (Avandia) |
Annual Revenue: $39.0 billion USD (2% FY 2004) | Employees: 100,019 | Stock Symbol: LSE: GSK NYSE: GSK | Website: www.gsk.com |